Amit Reddy, MD
Retina Specialist · Aurora, CONPI 1457714081
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,240 of the $4,240 with a category attached, or 76.4%. Eyepoint US, Inc. accounts for 79.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $3,323 and has fallen 97.2% since, to $94 in 2025. That places this record below the midpoint for retina specialist clinicians in CO, where the typical reported total is $4,083.
Across 19 payments — averaging $223.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eyepoint US, Inc.$3K
- Boston Scientific$242
- Bausch & Lomb Americas Inc.$220
- Alimera Sciences, Inc.$193
- ANI Pharmaceuticals, Inc.$59
- Johnson & Johnson$57
- plus $88 from 3 others
What the payments were for
- Consulting fees$3,24076%
- Food & beverage$1,00024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eyepoint US, Inc. | 4 | $3,382 |
| Boston Scientific | 3 | $242 |
| Bausch & Lomb Americas Inc. | 2 | $220 |
| Alimera Sciences, Inc. | 3 | $193 |
| ANI Pharmaceuticals, Inc. | 2 | $59 |
| Johnson & Johnson | 2 | $57 |
| Astellas Pharma US Inc | 1 | $51 |
| Amgen | 1 | $24 |
| Genentech, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- YUTIQ$3,240
- rezum Generator$123
- LithoVue$104
How this compares
$4,240 in reported general payments places this provider in the 50th percentile of 51 retina specialist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 31 | $209,907 |
| Prednisolone Acetate | 154 | $7,618 |
| Mycophenolic AcidMycophenolate Sodium | 17 | $4,887 |
| Mycophenolate Mofetil | 25 | $3,376 |
| Difluprednate | 23 | $2,973 |
| ValacyclovirValacyclovir Hcl | 33 | $2,952 |
| Fluorometholone | 22 | $1,906 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $1,554 |
| Brimonidine Tartrate | 42 | $1,083 |
| MoxifloxacinMoxifloxacin Hcl | 33 | $980 |
| MethotrexateMethotrexate Sodium | 75 | $803 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 53 | $774 |
| Ketorolac Tromethamine | 14 | $689 |
| Prednisolone | 11 | $575 |
| Prednisone | 72 | $568 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Aurora
- Talisa ForestAurora$84K
- Lynn HassmanAurora$16K
- Zachary KoretzAurora$14K
- Ross ChodAurora$10K
- Niranjan ManoharanAurora$9K
- Rachel ChenAurora$4K
- Naresh MandavaAurora$3K
- Frank SiringoAurora$3K
- Abraham HangAurora$2K
- Sean RodriguezAurora$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.